✦ LIBER ✦

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184

✍ Scribed by Helen J. Mackay; Anna Tinker; Eric Winquist; Gillian Thomas; Kenneth Swenerton; Amit Oza; Joana Sederias; Percy Ivy; Elizabeth A. Eisenhauer

Book ID: 113962190
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 186 KB
Volume: 116
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2009.08.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

907 ORAL A Phase II study of temsirolimu

907 ORAL A Phase II study of temsirolimus (CCI-779) in patients with metastatic and/or recurrent endometrial cancer — NCIC CTG IND 160

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

A phase II trial of zd0473 in patients w

A phase II trial of zd0473 in patients with metastatic breast cancer. A National Cancer Institute of Canada clinical trials group study (NCIC CTG-IND 129)

✍ T.A. Vandenberg; K.A. Gelmon; L. Panasci; M. Crump; B. Norris; A. Tomiak; T. She 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 166 KB

NCIC CTG IND102: a phase II study of the

NCIC CTG IND102: a phase II study of the oral platinum compound BMS-182751 in patients with advanced and or recurrent squamous cell carcinoma of the cervix

✍ M. Trudeau; G. Stuart; H. Hirte; P. Drouin; M. Plante; P. Bessette; H. Dulude; D 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase II study of sunitinib as maintenan

Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer

✍ Gervais, Radj; Hainsworth, John D.; Blais, Normand; Besse, Benjamin; Laskin, Jan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Phase I study of Tomudex and Doxorubicin

Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98)

✍ Georg A. Bjarnason; Danielle Charpentier; Ralph Wong; Rakesh Goel; Lynn Douglas; 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 62 KB

A phase II, open-label study of gefitini

A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma

✍ Monika Jermann; Rolf A Stahel; Marc Salzberg; Thomas Cerny; Markus Joerger; Silk 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 226 KB